PTGS2 and nasopharyngeal carcinoma: We profiled the expression level of the five shortlisted targets in each cell type, showing that NTRK2, PTGS2, and ROBO1 were expressed in both EBV+ and EBV- NPC cells, whereas CACNA2D1 and DUSP10 were specifically expressed in EBV+ NPC cells.